Right ventricle free wall rupture during transcatheter occluder implantation in a patient with postinfarction rupture of the interventricular septum and COVID-19-associated myocarditis. Case report
- Authors: Pevzner D.V.1, Sukhinina T.S.1, Anufriev E.N.1, Kostritca N.S.1, Avetisyan E.A.1, Shitov V.N.1, Kurilina E.V.1, Osiev A.G.2, Merkulov E.V.1, Tereshchenko A.S.1, Boytsov S.A.1
-
Affiliations:
- Chazov National Medical Research Center of Cardiology
- MEDSI Group of Companies
- Issue: Vol 95, No 7 (2023)
- Pages: 574-579
- Section: Clinical notes
- URL: https://journals.rcsi.science/0040-3660/article/view/148299
- DOI: https://doi.org/10.26442/00403660.2023.07.202330
- ID: 148299
Cite item
Full Text
Abstract
Intraventricular septum rupture is a rare mechanic complication of myocardial infarction associated with high mortality. This case describes STEMI in recovered patient after COVID 19 associated pneumonia, which was complicated by ventricular septum rupture followed by cardiogenic shock. It was managed by percutaneous occluder implantation. The procedure was complicated by right ventricular wall rupture. Postmortem examination of myocardium showed the signs of inflammation infiltrate and myocyte necrosis, according to histopathological Dallas criteria diagnosis of COVID-19 associated myocarditis was established. The COVID-19 pandemic has contributed to increasing cardiovascular mortality. This is typically attributed to diminishing resources for timely and appropriate medical care, and patients’ late presentations for fear of contracting the infection. Cardiovascular complication of COVID-19 may be another contributing factor. Further research is needed to improve our understanding of the mechanisms and long-term sequelae of myocardium damage in COVID-19, to optimize treatment strategy and subsequent follow-up in such patients.
Full Text
##article.viewOnOriginalSite##About the authors
Dmitry V. Pevzner
Chazov National Medical Research Center of Cardiology
Author for correspondence.
Email: pevsner@mail.ru
ORCID iD: 0000-0002-5290-0065
канд. мед. наук, ст. науч. сотр., зав. блоком интенсивной терапии отд. неотложной кардиологии
Russian Federation, MoscowTatiana S. Sukhinina
Chazov National Medical Research Center of Cardiology
Email: pevsner@mail.ru
ORCID iD: 0000-0002-5509-6623
канд. мед. наук, ст. науч. сотр. отд. неотложной кардиологии
Russian Federation, MoscowEgor N. Anufriev
Chazov National Medical Research Center of Cardiology
Email: pevsner@mail.ru
ORCID iD: 0000-0002-9660-9851
врач-кардиолог отд. неотложной кардиологии
Russian Federation, MoscowNatalia S. Kostritca
Chazov National Medical Research Center of Cardiology
Email: pevsner@mail.ru
ORCID iD: 0000-0002-8746-8727
врач-ординатор отд. неотложной кардиологии
Russian Federation, MoscowEric A. Avetisyan
Chazov National Medical Research Center of Cardiology
Email: pevsner@mail.ru
ORCID iD: 0000-0002-0331-2179
врач-кардиолог отд. неотложной кардиологии
Russian Federation, MoscowVictor N. Shitov
Chazov National Medical Research Center of Cardiology
Email: pevsner@mail.ru
ORCID iD: 0000-0002-8878-7340
врач-кардиолог блока интенсивной терапии отд. неотложной кардиологии, врач ультразвуковой диагностики
Russian Federation, MoscowElla V. Kurilina
Chazov National Medical Research Center of Cardiology
Email: pevsner@mail.ru
ORCID iD: 0000-0002-3208-534X
зав. отд-нием патанатомии
Russian Federation, MoscowAleksandr G. Osiev
MEDSI Group of Companies
Email: pevsner@mail.ru
ORCID iD: 0000-0001-5263-0387
д-р мед. наук, проф., зав. отд-нием рентгенхирургии
Russian Federation, MoscowEvgeny V. Merkulov
Chazov National Medical Research Center of Cardiology
Email: pevsner@mail.ru
ORCID iD: 0000-0001-8193-8575
д-р мед. наук, ст. науч. сотр., зав. 1-м отд-нием рентгенхирургических методов диагностики и лечения
Russian Federation, MoscowAndrew S. Tereshchenko
Chazov National Medical Research Center of Cardiology
Email: pevsner@mail.ru
ORCID iD: 0000-0002-4198-0522
канд. мед. наук, ст. науч. сотр. отд. рентгенэндоваскулярных методов диагностики и лечения
Russian Federation, MoscowSergey A. Boytsov
Chazov National Medical Research Center of Cardiology
Email: pevsner@mail.ru
ORCID iD: 0000-0001-6998-8406
акад. РАН, д-р мед. наук, проф., ген. дир
Russian Federation, MoscowReferences
- Mubarik A, Iqbal AM. Ventricular Septal Rupture. 2022 Feb 14. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
- Birnbaum Y, Fishbein MC, Blanche C, Siegel RJ. Ventricular septal rupture after acute myocardial infarction. N Engl J Med. 2002;347(18):1426-32. doi: 10.1056/NEJMra020228
- Jones BM, Kapadia SR, Smedira NG, et al. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. Eur Heart J. 2014;35(31):2060-8. doi: 10.1093/eurheartj/ehu248
- Mahajan K, Shah N, Patel H. Post Infarct Ventricular Septal Rupture. 2021 Sep 28. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2022.
- Thiele H, Kaulfersch C, Daehnert I, et al. Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J. 2009;30(1):81-8. doi: 10.1093/eurheartj/ehn524
- Faccini A, Butera G. Techniques, Timing, and Prognosis of Transcatheter Post Myocardial Infarction Ventricular Septal Defect Repair. Curr Cardiol Rep. 2019;21(7):59. doi: 10.1007/s11886-019-1142-8
- Risseeuw F, Diebels I, Vandendriessche T, et al. Percutaneous occlusion of post-myocardial infarction ventricular septum rupture. Neth Heart J. 2014;22(2):47-51. doi: 10.1007/s12471-013-0498-4
- Shabestari MM, Ghaderi F, Hamedanchi A. Transcatheter Closure of Postinfarction Ventricular Septal Defect: A Case Report and Review of Literature. J Cardiovasc Thorac Res. 2015;7(2):75-7. doi: 10.15171/jcvtr.2015.17
- Holzer R, Balzer D, Amin Z, et al. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry. Catheter Cardiovasc Interv. 2004;61(2):196-201. doi: 10.1002/ccd.10784
- Dawson AG, Williams SG, Cole D. Does the placement of an Amplatzer septal occluder device confer benefit in patients with a post-infarction ventricular septal defect? Interact Cardiovasc Thorac Surg. 2014;19(6):1040-7. doi: 10.1093/icvts/ivu293
- Shahreyar M, Akinseye O, Nayyar M, et al. Post-Myocardial Infarction Ventricular Septal Defect: A Comprehensive Review. Cardiovasc Revasc Med. 2020;21(11):1444-9. doi: 10.1016/j.carrev.2018.11.017
- Fragkouli K, Mitselou A, Boumba V, et al. An autopsy case of necrotizing eosinophilic myocarditis causing left ventricular wall rupture. Forensic Sci Med Pathol. 2011;7(4):350-4. doi: 10.1007/s12024-011-9235-8
- Kondo T, Nagasaki Y, Takahashi M, et al. An autopsy case of cardiac tamponade caused by a ruptured ventricular aneurysm associated with acute myocarditis. Leg Med (Tokyo). 2016;18:44-8. doi: 10.1016/j.legalmed.2015.12.002
- Stock E, Lubbe T. Rupture of the right ventricle in acute myocarditis. Br Heart J. 1968;30(1):135-7. doi: 10.1136/hrt.30.1.135
- Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463-71. doi: 10.1016/j.hrthm.2020.05.001
- Greenberg A, Pemmasani G, Yandrapalli S, Frishman WH. Cardiovascular and Cerebrovascular Complications With COVID-19. Cardiol Rev. 2021;29(3):143-9. doi: 10.1097/CRD.0000000000000385
- Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124:188-95. doi: 10.1182/blood-2014-05-552729
- Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020;75(18):2352-71. doi: 10.1016/j.jacc.2020.03.031
- Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. doi: 10.1038/s41569-020-0360-5
- Rey JR, Jiménez Valero S, Poveda Pinedo D, et al. COVID-19 y trombosis simultánea en dos arterias coronarias [COVID-19 and simultaneous thrombosis of two coronary arteries]. Rev Esp Cardiol. 2020;73(8):676-8. doi: 10.1016/j.recesp.2020.05.004
- Bangalore S, Sharma A, Slotwiner A, et al. ST-Segment Elevation in Patients with Covid-19 – A Case Series. N Engl J Med. 2020;382(25):2478-80. doi: 10.1056/NEJMc2009020
- Lang JP, Wang X, Moura FA, et al. A current review of COVID-19 for the cardiovascular specialist. Am Heart J. 2020;226:29-44. doi: 10.1016/j.ahj.2020.04.025
- Lakhdar S, Buttar Ch, Perez L, et al. ST Elevation Myocardial Infarction in Patients with COVID-19: Case Series. EMJ. 2022;7:38-46.
- Kociol RD, Cooper LT, Fang JC, et al. American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association. Circulation. 2020;141(6):e6992. doi: 10.1161/CIR.0000000000000745